Loading...
•
Sep 30, 2024
Owens & Minor Q3 2024 Earnings Report
Owens & Minor's financial performance in Q3 2024 reflected top-line growth driven by patient direct and medical distribution demand and total debt reduction.
Key Takeaways
Owens & Minor reported a 5% increase in consolidated revenue, reaching $2.7 billion. The company experienced a GAAP net loss of $(13) million, but achieved an adjusted EPS of $0.42. Adjusted EBITDA grew by 5% to $142 million, and total debt was reduced by $198 million.
Consolidated revenue increased by 5% year-over-year, reaching $2.7 billion.
GAAP Net loss was $(13) million, with adjusted earnings per share at $0.42.
Adjusted EBITDA grew by 5% year-over-year to $142 million.
Total debt was reduced by $198 million in the third quarter.
Owens & Minor
Owens & Minor
Forward Guidance
The company anticipates good sequential growth and cash flow from the third to fourth quarter, positioning them well for 2025. Each segment is expected to benefit from seasonality and recent investments as they finish 2024.